Induced Resistance to Ofatumumab Mediated Cell Clearance Mechanisms, Including Complement Dependent Cytotoxicity, in Chronic Lymphocytic Leukemia

Những quyển sách tương tự

• Complement dependent cytotoxicity (CDC) in chronic lymphocytic leukemia (CLL): Ofatumumab enhances alemtuzumab CDC and reveals cells resistant to activated complement
  Bằng: Baig, Nisar A., et al.
  Được phát hành: (2012)
• Direct and Complement Dependent Cytotoxicity in CLL Cells from Patients with High Risk Early Stage Chronic Lymphocytic Leukemia (CLL) Treated with Alemtuzumab and Rituximab
  Bằng: Zent, Clive S., et al.
  Được phát hành: (2008)
• Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated CLL
  Bằng: Shanafelt, Tait, et al.
  Được phát hành: (2013)
• MBL or CLL: Which Classification Best Categorizes the Clinical Course of Patients with an Absolute Lymphocyte Count ≥5 × 10(9)/L but a B-cell Lymphocyte Count <5 × 10(9)/L?
  Bằng: Shanafelt, Tait D., et al.
  Được phát hành: (2008)
• Percentage of Smudge Cells on Routine Blood Smear Predicts Survival in Chronic Lymphocytic Leukemia
  Bằng: Nowakowski, Grzegorz S., et al.
  Được phát hành: (2009)